Glanbia (LSE:GLB) posted a solid performance in the first half of 2025, recording a 6% year-on-year revenue increase to $1.93 billion, fueled by strong gains in both Health & Nutrition and Dairy Nutrition divisions. While EBITDA and adjusted EPS experienced a decline, the company lifted its full-year guidance, citing stronger revenue momentum and improving margins.
Key strategic actions during the period included acquiring Brazilian-based Sweetmix and divesting Body & Fit. Glanbia also announced a 10% rise in its interim dividend and continued share buybacks, underscoring its disciplined capital allocation and commitment to shareholder value.
About Glanbia plc
Glanbia plc is a global leader in nutrition, serving the Health & Nutrition and Dairy Nutrition markets. The company specializes in delivering innovative nutritional solutions and products, catering to the growing demand from health-conscious consumers and the performance nutrition sector.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply